Expanded Access for ABI-009 in Patients With Advanced PEComa and Patients With a Malignancy With Relevant Genetic Mutations or mTOR Pathway Activation
Clinical trial NCT03817515 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT03817515
- Sponsor
- Aadi Bioscience, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.